10 completed, 4 unknown, 1 not yet recruiting, 1 suspended. 11 Not applicable, 2 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 11 | Completed 7, Unknown 2, Suspended 1, Withdrawn 1 |
| Phase 3 | 2 | Completed 2 |
| Phase 4 | 1 | Unknown 1 |
Follow Central Line-associated Bloodstream Infection (CLABSI): new trials by email Literature Review of Central Line-associated Bloodstream Infection (CLABSI) trials Research Report on Central Line-associated Bloodstream Infection (CLABSI)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Central Line-Associated Bloodstream Infection QI Project Central Line-associated Bloodstream Infection (CLABSI) | Not yet recruiting | NYU Langone Health | 30 | 2026-09-01 | 2026-08-05 | |
| Determining the Prevalence of Primary and Secondary Central Line Associated Blood Stream Infection (CLABSI) at the Tertiary Care Hospital Blood Catheters - Central Line-associated Bloodstream Infection (CLABSI) | Unknown | Port Said University | 600 | 2024-06-25 | 2024-06-13 | |
| The Association Between Chlorhexidine Bathing and Central Line-Associated Infections in Medical Intensive Care Units Chlorhexidine bathing - Central Line-associated Bloodstream Infection (CLABSI) | Completed | National Taiwan University Hospital | 6930 | 2023-04-12 | 2023-06-27 | |
| Daily Chlorexidine Bath for Health Care Associated Infection Prevention 2% chlorhexidine digluconate solution with surface-active agents, Usual Baths - Health Care Associated Infection, Ventilator Associated Pneumonia | Phase 3 | Completed | Hospital do Coracao | 15730 | 2022-08-03 | 2024-06-13 |
| Hydrochloric Acid Lock Therapy for Central Line-associated Bloodstream Infections Hydrochloric Acid (2 M), Normal saline - Central Line-associated Bloodstream Infection (CLABSI) | Not applicable | Completed | Copenhagen University Hospital, Rigshospitalet | 212 | 2022-06-01 | 2026-03-24 |
| CLiCK in the Critical Care Unit 4% EDTA, Saline - Central Venous Catheter Thrombosis, Central Venous Catheter Related Bloodstream Infection | Not applicable | Completed | Fraser Health | 1449 | 2022-03-22 | 2025-02-28 |
| Effect of Vancomycin After Catheter Replacement Vancomycin - Central Line-associated Bloodstream Infection (CLABSI), Catheter-related Bloodstream Infection | Phase 4 | Unknown | University of Zurich | 100 | 2021-06-01 | 2021-04-29 |
| Compassionate-Use of 4% T-EDTA Lock Solution for Central Venous Lines of Pediatric PN Patients Tetrasodium EDTA Catheter Lock Solution - Central Line Complication, Central Line-associated Bloodstream Infection (CLABSI) | Not applicable | Suspended | Boston Children's Hospital | 15 | 2020-12-21 | 2026-04-15 |
| Central Line-associated Bloodstream Infection Prevention Using TauroLock-Hep100 in Pediatric Oncology Patients. TauroLock-Hep100 (taurolidine 1.35%, citrate 4%, heparin 100 IU/mL), Heparin lock (heparin 100 IU/mL) - Central Line-associated Bloodstream Infection (CLABSI) | Not applicable | Unknown | Princess Maxima Center for Pediatric Oncology | 462 | 2020-10-27 | 2023-02-22 |
| Implementation Program to Improve CHG Bathing Compliance CHG Education - Central Line-associated Bloodstream Infection (CLABSI) | Not applicable | Completed | Duke University | 14 | 2019-05-01 | 2022-07-20 |
| Central Venous Catheter Insertion Site and Colonization in Pediatric Cardiac Surgery Internal jugular vein CVC insertion - Central Line-associated Bloodstream Infection (CLABSI), Central Venous Catheter Associated Bloodstream Infection | Not applicable | Withdrawn | IRCCS Policlinico S. Donato | 2017-09-12 | 2023-11-18 | |
| Ethanol-lock Therapy for the Prevention of Non-tunneled Catheter-related Infection in Pediatric Patients Ethanol-lock - Infection, Catheter-Related, Central Line-associated Bloodstream Infection (CLABSI) | Phase 3 | Completed | Instituto Materno Infantil Prof. Fernando Figueira | 120 | 2016-03-01 | 2019-11-01 |
| The Effects of Different Ways of Dressing Central Line Associated Bloodstream Infections full aseptic dressing - Central Line-associated Bloodstream Infection (CLABSI) | Not applicable | Completed | National Taiwan University Hospital Hsin-Chu Branch | 331 | 2015-08-20 | 2018-10-02 |
| Patient Safety Learning Laboratory: Making Acute Care More Patient-Centered Patient Safety health information technology - Central Line-Associated Bloodstream Infection (CLABSI), Venous Thromboembolism | Not applicable | Completed | Brigham and Women's Hospital | 21000 | 2015-04-01 | 2019-07-10 |
| Umbilical Cord Care for the Prevention of Colonization Povidone-Iodine, Chlorhexidine gluconate, Pluronic Cream - Line Insertion Site, Central Line-associated Bloodstream Infection (CLABSI) | Not applicable | Unknown | University of Virginia | 100 | 2013-07-01 | 2013-08-02 |
| Port Protectors for Prevention of CLABSIs in Respiratory Semi-intensive Care Unit Training and retraining to GAVECELT "bundle" recommendations plus port protector, Training and retraining to GAVECELT "bundle" recommendations - Central Line-associated Bloodstream Infection (CLABSI) | Not applicable | Completed | Catholic University of the Sacred Heart | 132 | 2013-04-01 | 2018-04-03 |
| Safe Critical Care: Testing Improvement Strategies Collaborative Group, Tool Kit - Central Line-associated Bloodstream Infection (CLABSI), Ventilator Associated Pneumonia | Not applicable | Completed | Vanderbilt University | 59 | 2006-02-01 | 2016-01-12 |
Catheter-Related Infections (2) · Pneumonia, Ventilator-Associated (2) · Sepsis (2) · Cross Infection (1) · Drug-Related Side Effects and Adverse Reactions (1) · Heart Defects, Congenital (1) · Hyperphagia (1) · Hypoglycemia (1) · Infections (1) · Intestinal Failure (1) · Neoplasms (1) · Premature Birth (1) · Upper Extremity Deep Vein Thrombosis (1) · Venous Thromboembolism (1)
Infections (6) · Pathological Conditions, Signs and Symptoms (5) · Pathologic Processes (4) · Cardiovascular Diseases (3) · Disease Attributes (2) · Embolism and Thrombosis (2) · Healthcare-Associated Pneumonia (2) · Iatrogenic Disease (2) · Inflammation (2) · Lung Diseases (2) · Pneumonia (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Systemic Inflammatory Response Syndrome (2) · Vascular Diseases (2)
Ethanol (1) · Hydrochloric Acid (1) · Methods (1) · Poloxamer (1) · Povidone-Iodine (1) · Quality Improvement (1) · Saline Solution (1) · Soaps (1) · Surface-Active Agents (1) · Vancomycin (1) · Vascular Access Devices (1) · chlorhexidine gluconate (1)
Boston Children's Hospital (1) · Brigham and Women's Hospital (1) · Catholic University of the Sacred Heart (1) · Copenhagen University Hospital, Rigshospitalet (1) · Duke University (1) · Fraser Health (1) · Hospital do Coracao (1) · IRCCS Policlinico S. Donato (1) · Instituto Materno Infantil Prof. Fernando Figueira (1) · NYU Langone Health (1) · National Taiwan University Hospital (1) · National Taiwan University Hospital Hsin-Chu Branch (1) · Port Said University (1) · Princess Maxima Center for Pediatric Oncology (1) · University of Virginia (1)
United States (6) · Brazil (2) · Canada (1) · Denmark (1) · Egypt (1) · Italy (1) · Netherlands (1) · Taiwan (1)
Alexandre B Cavalcanti, M.D (1) · Bellisa C Lopes, Master (1) · Bruno M Tomazini, M.D (1) · David A Kaufman, MD (1) · David W Bates, MD MSc (1) · Giuseppe M Corbo, MD, Prof. (1) · Holly Krelle (1) · Marco Ranucci, MD (1) · Mark Puder, MD, PhD (1) · Meng-lan Teng (1) · Riccardo Inchingolo, MD, PhD (1) · Staci Reynolds, PhD (1) · Steven Reynolds, MD (1) · Theodore Speroff, PhD (1) · Ulrikka Nygaard, MD, ph.d. (1)
PMID 10362409, PMID 12797890, PMID 15857534, PMID 17875082, PMID 17994522, PMID 18951395, PMID 19237884, PMID 20125046, PMID 21312329, PMID 28471906, PMID 28585784, PMID 2921683, PMID 29941012, PMID 30832598, PMID 33201236, PMID 3379183, PMID 33902653, PMID 35617584, PMID 36042488, PMID 36944461, PMID 38837803, PMID 41732706, PMID 42150112, PMID 8870910